Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation

Objective - to conduct a pharmacoeconomic analysis of using omalizumab, mepolizumab and reslizumab in the treatment of patients with uncontrolled moderate and severe atopic asthma in the healthcare setting of the Russian Federation.Materials and Methods. A pharmacoeconomic model based on clinical da...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: S. K. Zyryanov (Author), I. N. Diyakov (Author), S. N. Avdeev (Author)
Hōputu: Pukapuka
I whakaputaina: IRBIS LLC, 2020-02-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

Connect to this object online.

3rd Floor Main Library

Ngā taipitopito puringa mai i 3rd Floor Main Library
Tau karanga: A1234.567
Tārua 1 Wātea